NITI Aayog releases a roadmap for expanding India’s bioeconomy to about $2.6 trillion by 2047, aiming to position the country among the world’s leading biotech powers. The plan targets growth from an estimated $195.3 billion in 2025, and outlines a “mission-mode” execution approach to drive implementation. According to the report, achieving the long-term target requires coordinated action across sectors, including biotechnology development, scaling of bio-based industries, and enabling conditions for investment and innovation.
One of the proposals in the roadmap includes the creation of a ₹50,000 crore fund to support biotech-related activities. The report also calls for financing measures and regulatory reforms to reduce barriers for industry and support faster commercialization. Both outlets describe the strategy as part of a structured long-term pathway for building capabilities and expanding the bioeconomy, with the objective of strengthening India’s global competitiveness in biotechnology by the middle of the century.
